A Phase 2 Trial of Capecitabine Concomitantly With Whole Brain Radiotherapy(WBRT) Followed by Capecitabine and Sunitinib for Central Nervous System, (CNS) Metastases in Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Feb 2014
At a glance
- Drugs Capecitabine (Primary) ; Sunitinib (Primary)
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 02 Oct 2012 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 24 Jan 2012 Actual initiation date changed from Dec 2007 to Feb 2009 as reported by ClinicalTrials.gov.
- 24 Jan 2012 Planned End Date changed from 1 Dec 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.